Coenzyme Q10

Mechanism of action: energy and antioxidants

Coenzyme Q10 has two central and complementary functions:

• Component of the Mitochondrial Electron Transport Chain — CoQ10 is a mobile electron carrier in the inner mitochondrial membrane, where it transports electrons from complex I and II to complex III of the respiratory chain. This process is essential for ATP synthesis through oxidative phosphorylation. In the absence of CoQ10, cellular energy production stops. Cells with the highest energy requirements — cardiomyocytes, neurons, muscle cells-are those most affected by its deficiency.
• Liposoluble Antioxidant — In its reduced form (ubiquinol), CoQ10 is a major fat-soluble antioxidant in cell membranes and plasma lipoproteins. It neutralizes free radicals in lipid membranes, protecting phospholipids from oxidation. It also helps regenerate oxidized Vitamin E, inserting itself into the cellular antioxidant chain along with Vitamin C and Glutathione.

Statins and Coenzyme Q10 Depletion

Statins — the most widely prescribed class of drugs for LDL cholesterol reduction — inhibit the enzyme HMG-CoA reductase, the same enzyme involved in the synthesis of endogenous CoQ10. Statin therapy significantly reduces plasma and tissue levels of CoQ10, with a documented correlation with statin myopathy — the muscle weakness that is the most common adverse effect of these drugs. CoQ10 supplementation in patients on statin therapy is one of the most studied clinical applications, with evidence suggesting a reduction in the intensity of myopathy, although study results are not uniform.

Those on statin therapy who are considering Coenzyme Q10 supplementation should do so in consultation with their treating physician, who will be able to assess the appropriateness and appropriate dosage in the context of ongoing drug therapy.

Food Sources

Coenzyme Q10 is present in small amounts in numerous foods. The richest sources are organ meats — heart, liver, kidney — followed by beef, oily fish (mackerel, sardines, tuna), peanuts, and soybeans. Vegetables contain much lower concentrations. The average intake through the diet is estimated at 3–5 mg per day — amounts far from the doses used in clinical studies, which generally range from 100 to 400 mg per day.

Key clinical evidence

Areas with the most robust evidence for Coenzyme Q10 include:

• Heart Failure — The Q-SYMBIO study (2014), the largest randomized controlled trial on CoQ10 in heart failure, documented a significant reduction in cardiovascular mortality and major adverse events in the group treated with 300 mg/day of CoQ10 compared with placebo. It is one of the most significant findings in the literature on CoQ10.
• Hypertension — meta-analysis shows significant reductions in systolic and diastolic blood pressure with CoQ10 supplementation.
• Physical Performance and Recovery — Evidence on reduced muscle fatigue and improved aerobic performance, particularly in those over 50 with reduced basal levels of CoQ10.
• Male Fertility — CoQ10 is present in high concentration in sperm, where it plays a role in motility and protection from oxidative stress. Clinical studies document improvements in seminal parameters with prolonged supplementation.
• Migraine — evidence of reduced frequency of migraine episodes with CoQ10 supplementation, with a proposed mechanism related to mitochondrial dysfunction in brain tissue.

Ubichinone vs Ubichinol: which form to choose

The debate between the two forms of CoQ10 is one of the most hotly debated topics in formulation. The positions have become clearer in recent years:

• Ubiquinone — the traditional, more stable and less expensive form. The young, healthy body effectively converts ubiquinone to ubiquinol. At equivalent doses, in young, healthy subjects, the difference in bioavailability to ubiquinol is limited if ubiquinone is well formulated (optimized crystalline dispersion).
• Ubichinol — the already active form, not requiring conversion. More relevant after age 35–40 years, when conversion capacity decreases, under high oxidative stress, in subjects on statin therapy, and in formulations for longevity and cardiovascular support. Generally higher bioavailability at the same dose.

One technical element that is often underestimated: the bioavailability of CoQ10 — in both forms — critically depends on the physical state of the molecule in the formulation. Crystalline CoQ10 has low bioavailability; formulations with amorphous dispersion, oil solubilization, or nanosuspension technologies show significantly higher absorption. The choice of molecular form (ubiquinone vs ubiquinol) is less of a determinant of formulation quality.

Vitamin C, Omega-3 and Magnesium: the synergies in formulation

Coenzyme Q10 fits naturally into multi-target formulations for cardiovascular health and longevity. Vitamin C supports regeneration of oxidized ubiquinol, amplifying cellular antioxidant protection. Omega-3 contributes to the fluidity of mitochondrial membranes, facilitating electron transport in which CoQ10 plays a leading role. Magnesium is a cofactor of enzymes in the mitochondrial respiratory chain and contributes to cellular energy metabolism-completing an integrated system of support for mitochondrial function.

The regulatory framework: absence of EFSA claims.

Coenzyme Q10 has no EFSA-approved health claims under EC Regulation 1924/2006. EFSA evaluated applications for CoQ10 and rejected them, finding the available evidence insufficient to establish a causal relationship between CoQ10 intake and claimed health effects. This is not to say that CoQ10 is without documented effects-the scientific literature is extensive and growing — but that the level of evidence required for approval of an EFSA claim has not been met for any of the proposed applications as of the current date.

In Italy, the Ministry of Health allows the use of Coenzyme Q10 in dietary supplements without requiring specific approved claims. Functional claims that can be used on the label must be nontherapeutic, not misleading and consistent with the nature of the supplement.

Coenzyme Q10 can interact with anticoagulant drugs (warfarin), reducing their effectiveness. Those on anticoagulant therapy should consult their doctor before supplementing.

Always remember that it is important to consult a health care professional before starting any new supplement or treatment.